dfcomb: An R-package for phase I/II trials of drug combinations

机译：dfcomb：用于药物组合的I / II期试验的R包

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

International audience

机译：国际观众

著录项

作者
Riviere, Marie-Karelle; Jourdan, Jacques-Henri; Zohar, Sarah;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. dfcomb: An R-package for phase I/II trials of drug combinations [J] . Riviere Marie-Karelle, Jourdan Jacques-Henri, Zohar Sarah Computer Methods and Programs in Biomedicine: An International Journal Devoted to the Development, Implementation and Exchange of Computing Methodology and Software Systems in Biomedical Research and Medical Practice . 2016,第1期

机译：dfcomb：用于药物组合的I / II期试验的R-package
2. Analyses of drug combinations using missing data shortens trial periods in phase I/II oncology trials [J] . Shinjo Yada, Chikuma Hamada Contemporary Clinical Trials Communications . 2017,第1期

机译：使用缺失数据进行药物组合分析可缩短I / II期肿瘤学试验的试验周期
3. Tofacitinib in Combination With Conventional Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis: Patient-Reported Outcomes From a Phase III Randomized Controlled Trial [J] . Strand Vibeke, Kremer Joel M., Gruben David, Arthritis care & research . 2017,第4期

机译：TOFACITINIB与患有活性类风湿性关节炎患者的常规疾病修饰的抗逆素药物组合：来自III期随机对照试验的患者报告的结果
4. Clinical studies of SP1049C, a polymer based anthracycline effective against drug resistant tumors. Results of phase II trial and pivotal phase Ⅲ program in upper gastrointestinal cancer indications [C] . Valery Alakhov Controlled Release Society Annual Meeting and Exposition . 2007

机译：SP1049C的临床研究，一种基于聚合物的蒽环类药物可有效抵抗耐药性肿瘤。上消化道癌适应症的II期试验和关键性III期试验结果
5. Clinical predictive value of pre-clinical cancer models: A study of the predictive value of the in vitro cell line, human xenograft and murine allograft pre-clinical cancer models for phase II clinical trials of cytotoxic cancer drugs [D] . Voskoglou-Nomikos, Theodora 2001

机译：临床前癌症模型的临床预测价值：体外细胞系，人异种移植和小鼠同种异体移植临床前癌症模型对细胞毒性癌症药物II期临床试验的预测价值研究
6. Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs [O] . Geraint Davies, Martin Boeree, Dave Hermann, 2019

机译：加速新的结核病药物组合从II期试验过渡到III期试验：新技术和创新设计
7. dfcomb: An R-package for phase I/II trials of drug combinations [O] . Riviere Marie-Karelle, Jourdan Jacques-Henri, Zohar Sarah 2016

机译：dfcomb：用于药物组合的I / II期试验的R包

dfcomb: An R-package for phase I/II trials of drug combinations

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅